On February 14 ProMIS Neurosciences (PMN) separated with Gavin T. Malenfant as Chief Operating Officer of the Company, effective as of February 14… In connection with the Separation, Malenfant and the company intend to enter into a Separation Agreement pursuant to which Malenfant will receive severance benefits in exchange for a release pursuant to the terms of his employment agreement with the company… The company also terminated the Chief Operating Officer position, and does not intend to replace Mr. Malenfant. This information is contained in a company 8k filing…
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PMN:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue